GL1X · GenesisL1 explorer

Research workbench

Pyranose 2-oxidase V546C mutant with 2-fluorinated galactose

Analyse Pyranose 2-oxidase V546C mutant with 2-fluorinated galactose in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MOQ
Type
protein
Length
1,141 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pyranose 2-oxidase
EC
1.1.3.10
UniProt
Q7ZA32
Ligands
2FG, FDA
Pockets
13 · best druggability 0.88

Structure

x-ray diffraction · 2 distinct chains · 25% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APyranose 2-oxidase (EC 1.1.3.10)protein56925% helix, 24% strandQ7ZA32
BPyranose 2-oxidase (EC 1.1.3.10)protein57225% helix, 24% strandQ7ZA32

Ligands and binding sites

  • 2FG · 2-deoxy-2-fluoro-beta-D-galactopyranose · ligand · 3 copies · chains A, B
  • FDA · Dihydroflavine-adenine dinucleotide · ligand · 2 copies · chains A, B
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15240.880.9463FDA, 2FG
25230.880.9464FDA, 2FG
39990.800.8176empty
48050.790.8375empty
53580.750.8670empty

Interfaces

1 interface between chains.

  • A–B · 2704 Ų buried · 39 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4MOQ · Pyranose 2-oxidase V546C mutant with 2-fluorinated galactose · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.